Literature DB >> 2992805

Activation of a novel human transforming gene, ret, by DNA rearrangement.

M Takahashi, J Ritz, G M Cooper.   

Abstract

A novel transforming gene was detected by transfection of NIH 3T3 cells with human lymphoma DNA. The tumor DNA induced a single focus in primary transfections, whereas DNAs of transformed NIH cells induced transformation with high efficiencies in secondary and tertiary assays. Molecular clones spanning about 37 kb of human sequence were isolated from tertiary transformant DNA. Blot hybridization indicated that the transforming gene consisted of two segments that were unlinked in both normal human and primary lymphoma DNAs. The two segments of human DNA were cotranscribed in transformed NIH cells but not in any human cells examined. The transforming gene thus appeared to be activated by recombination between two unlinked human DNA segments, possibly by cointegration during transfection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992805     DOI: 10.1016/0092-8674(85)90115-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  197 in total

1.  Ret finger protein inhibits muscle differentiation by modulating serum response factor and enhancer of polycomb1.

Authors:  H J Kee; J-R Kim; H Joung; N Choe; S E Lee; G H Eom; J C Kim; S H Geyer; M Jijiwa; T Kato; K Kawai; W J Weninger; S B Seo; K-I Nam; M H Jeong; M Takahashi; H Kook
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  The many faces of RET dysfunction in kidney.

Authors:  Sanjay Jain
Journal:  Organogenesis       Date:  2009-10       Impact factor: 2.500

Review 3.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

4.  RFP is a DNA binding protein associated with the nuclear matrix.

Authors:  T Isomura; K Tamiya-Koizumi; M Suzuki; S Yoshida; M Taniguchi; M Matsuyama; T Ishigaki; S Sakuma; M Takahashi
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

5.  Chipping away at the lung cancer genome.

Authors:  William Pao; Katherine E Hutchinson
Journal:  Nat Med       Date:  2012-03-06       Impact factor: 53.440

6.  The frequency of selected polymorphic variants of the RET gene in patients with medullary thyroid carcinoma and in the general population of central Poland.

Authors:  Maria Sromek; Malgorzata Czetwertyńska; Elzbieta Skasko; Joanna Zielińska; Dorota Czapczak; Jan Steffen
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

7.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.

Authors:  S Katzav; J L Cleveland; H E Heslop; D Pulido
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

Review 8.  To bud or not to bud: the RET perspective in CAKUT.

Authors:  T Keefe Davis; Masato Hoshi; Sanjay Jain
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

9.  Efficacy and Tolerability of Pyrazolo[1,5-a]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma.

Authors:  Casey J N Mathison; Donatella Chianelli; Paul V Rucker; John Nelson; Jason Roland; Zhihong Huang; Yang Yang; Jiqing Jiang; Yun Feng Xie; Robert Epple; Badry Bursulaya; Christian Lee; Mu-Yun Gao; Jennifer Shaffer; Sergio Briones; Yelena Sarkisova; Anna Galkin; Lintong Li; Nanxin Li; Chun Li; Su Hua; Shailaja Kasibhatla; Jacqueline Kinyamu-Akunda; Rie Kikkawa; Valentina Molteni; John E Tellew
Journal:  ACS Med Chem Lett       Date:  2020-02-12       Impact factor: 4.345

10.  Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing.

Authors:  Zhen-Fang DU; Peng-Fei Li; Jian-Qiang Zhao; Zhi-Lie Cao; Feng Li; Ju-Ming Ma; Xiao-Ping Qi
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.